Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
Clinical trial NCT05399498 · COMPLETED
Trial details
- NCT number
- NCT05399498
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-12-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.